Skip to main content

Table 1 Baseline characteristics of the DPS and Genobin study participants

From: Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study

  DPS Genobin
Males (n)/Females (n) 160/324 29/27
Age (y) 55.2 ± 7.0 (484) 59.4 ± 6.8 (56)
Weight (kg) 86.3 ± 14.2 (484) 92.8 ± 14.0 (56)
BMI (kg/m2) 31.2 ± 4.5 (484) 32.7 ± 2.9 (56)
Waist circumference (cm) 101.2 ± 11.0 (482) 108.9 ± 8.9 (56)
Fasting plasma glucose (mmol/L) 6.13 ± 0.75 (484) 6.44 ± 0.49 (56)
2-h plasma glucose (mmol/L) 8.88 ± 1.49 (484) 7.42 ± 2.15 (56)
Fasting serum insulin (mU/L) 14.73 ± 7.46 (439) 11.96 ± 7.29 (56)
2-h serum insulin (mU/L) 95.57 ± 65.83 (436) 83.38 ± 72.92 (56)
Serum total cholesterol (mmol/L) 5.61 ± 0.93 (483) 5.16 ± 0.98 (56)
Serum HDL cholesterol (mmol/L) 1.21 ± 0.29 (483) 1.23 ± 0.22 (56)
Serum LDL cholesterol (mmol/L) 3.62 ± 0.84 (481) 3.37 ± 0.91 (56)
Serum triglycerides (mmol/l) 1.73 ± 0.78 (483) 1.66 ± 0.84 (56)
Diastolic blood pressure (mmHg) 86 ± 10 (479) 89 ± 10 (56)
Systolic blod pressure (mmHg) 138 ± 17 (479) 136 ± 14 (56)
  1. Data are mean ±SD